Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Medical Data Vision Co's net current asset value per share for the quarter that ended in Dec. 2025 was 円43.88.
The historical rank and industry rank for Medical Data Vision Co's Net Current Asset Value or its related term are showing as below:
TSE:3902'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 9.29 Med: 15.72 Max: 38.47
Current: 38.38
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Medical Data Vision Co was 38.47. The lowest was 9.29. And the median was 15.72.
TSE:3902's Price-to-Net-Current-Asset-Value is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 6.3
vs TSE:3902: 38.38
Medical Data Vision Co (TSE:3902) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Medical Data Vision Co Net Current Asset Value Related Terms
Medical Data Vision Co Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Medical Data Vision Co's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Data Vision Co Net Current Asset Value Chart
TSE:3902 vs VEEV, TEM, BTSG: Net Current Asset Value Comparison
For the Health Information Services subindustry, Medical Data Vision Co's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Data Vision Co Price-to-Net-Current-Asset-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Medical Data Vision Co's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of 円43.88 mean?
Medical Data Vision Co (TSE:3902) has a Net Current Asset Value of 円43.88 as of Dec. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Medical Data Vision Co and its competitors. This is 179% above median its historical median of 15.72. Over the past decade, Medical Data Vision Co's Net Current Asset Value has ranged from 9.29 to 38.47.
Is Medical Data Vision Co's Net Current Asset Value too high?
Medical Data Vision Co's current Net Current Asset Value of 円43.88 is 179% above median its 10-year median of 15.72. Over the past 10 years, this metric has ranged from a low of 9.29 to a high of 38.47. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's Net Current Asset Value compare to VEEV and TEM?
Medical Data Vision Co's Net Current Asset Value of 円43.88 can be compared against companies in the Healthcare Providers & Services industry. The industry median Net Current Asset Value is 6.30. Historically, Medical Data Vision Co's own Net Current Asset Value has ranged from 9.29 to 38.47 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Healthcare Providers & Services company?
The median Net Current Asset Value among Healthcare Providers & Services companies is 6.30, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Medical Data Vision Co and its competitors. For the Healthcare Providers & Services industry, the median Net Current Asset Value is 6.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Data Vision Co's current Net Current Asset Value is 円43.88, which is 179% above median its own 10-year median of 15.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current Net Current Asset Value of 円43.88. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current Net Current Asset Value is 円43.88, which is 179% above median its 10-year median of 15.72. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current Net Current Asset Value is 円43.88 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued.
The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.
Key valuation signals for TSE:3902:
Net Current Asset Value: 円43.88 (179% above median its 10-year median of 15.72)
GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score
Get the complete analysis for TSE:3902
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3902 has been successfully added to your 
